ArticleFrontiers in pharmacology2024

Case report: One case of refractory membranous nephropathy with hypokalemia after rituximab infusion was switched to obinutuzumab without recurrence of hypokalemia.

Yao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.